ESTRO-EANO guideline on target delineation and radiotherapy for IDH-mutant WHO CNS grade 2 and 3 diffuse glioma

The GTV should include any residual tumour volume after surgery, as well as the resection cavity. Enhancing lesions on T1 imaging should be included if they are indicative of residual tumour. In grade 2 tumours, T2/FLAIR abnormalities should be included in the GTV. In grade 3 tumours, T2/FLAIR abnormalities should also be included, except areas that are considered to be oedema which should be omitted from the GTV. A GTV to CTV expansion of 10 mm is recommended in grade 2 tumours and 15 mm in grade 3 tumours. A treatment dose of 50.4 Gy in 28 fractions is recommended in grade 2 tumours and 59.4 Gy in 33 fractions in grade 3 tumours. Radiation techniques with IMRT are the preferred approach.

Authors

Institutions

Publication Details

Journal
Radiotherapy and Oncology
Published
2024-10-24
DOI
https://doi.org/10.1016/j.radonc.2024.110594
Citations
18
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
7.45
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ESTRO-EANO guideline on target delineation and radiotherapy for IDH-mutant WHO CNS grade 2 and 3 diffuse glioma

Martin J. van den Bent, Vera C. Keil, Anca-Ligia Grosu, Norbert Galldiks et al.
18 citations
Radiotherapy and Oncology
Glioma Diagnosis and Treatment
7.45
article

ESTRO-EANO guideline on target delineation and radiotherapy for IDH-mutant WHO CNS grade 2 and 3 diffuse glioma

Martin J. van den Bent, Vera C. Keil, Anca-Ligia Grosu, Norbert Galldiks, Sara Erridge, Umberto Ricardi, Damien C. Weber, Maximilian Niyazi, Jaap Jaspers, Brigitta G. Baumert, Ewa Iżycka‐Świeszewska, Giuseppe Caracciolo Minniti, F. Dhermain, Roberta Rudà, Beate Timmermann
article en
18 citations

Abstract

The GTV should include any residual tumour volume after surgery, as well as the resection cavity. Enhancing lesions on T1 imaging should be included if they are indicative of residual tumour. In grade 2 tumours, T2/FLAIR abnormalities should be included in the GTV. In grade 3 tumours, T2/FLAIR abnormalities should also be included, except areas that are considered to be oedema which should be omitted from the GTV. A GTV to CTV expansion of 10 mm is recommended in grade 2 tumours and 15 mm in grade 3 tumours. A treatment dose of 50.4 Gy in 28 fractions is recommended in grade 2 tumours and 59.4 Gy in 33 fractions in grade 3 tumours. Radiation techniques with IMRT are the preferred approach.

Radiotherapy and OncologyVol. 202
Radboud University Nijmegen (NL), University Medical Center Freiburg (DE), Institut Gustave Roussy (FR), Paul Scherrer Institute (CH), Edinburgh Cancer Research (GB), Radboud University Medical Center (NL), Düsseldorf University Hospital (DE), Integrated Oncology (United States) (US), Essen University Hospital (DE), University Children's Hospital Tübingen (DE), Bernstein Center for Computational Neuroscience Tübingen (DE), Kantonsspital Graubünden (CH), Erasmus MC Cancer Institute (NL), Amsterdam University Medical Centers (NL), University Hospital Cologne (DE), West German Heart and Vascular Center Essen (DE), Heinrich Heine University Düsseldorf (DE), University of Turin (IT), Gdańsk Medical University (PL), University of Tübingen (DE), Sapienza University of Rome (IT)
Zero hunger
Openalex Percentile: Top 2%
Glioma Diagnosis and Treatment
7.45
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.